rs3733197 — BANK1 A383T

BANK1 A383T — The Ankyrin Domain Variant That Links B-Cell Signaling to Multiple Autoimmune Diseases

BANK1 (B-cell scaffold protein with ankyrin repeats 1) is a signaling hub expressed exclusively in B cells. It connects the B-cell receptor (BCR) to downstream calcium mobilization by scaffolding LYN kinase, IP3 receptors, and PLCγ2 into a signaling complex that determines how strongly a B cell responds to antigen. Three functional variants in BANK1 contribute independently to autoimmune risk. The best-known is rs10516487 (R61H), which affects the N-terminal scaffold domain. The second is rs17266594, an intronic branch-point SNP affecting splicing. The third — rs3733197, the A383T variant — is located in the ankyrin repeat domain¹¹ ankyrin repeat domain
The ankyrin domain (amino acids ~309–402) mediates protein-protein interactions that position BANK1's signaling partners within the BCR complex, a structurally distinct region from both of the other variants. A383T is notable for its breadth: it has been associated with lupus, rheumatoid arthritis, systemic sclerosis, inflammatory myositis, and autoimmune thyroid disease — suggesting that the ankyrin domain's protein-docking function is broadly relevant to B-cell-driven autoimmunity.

The Mechanism

The BANK1 protein contains ankyrin repeats (amino acids ~309–402) that mediate interactions with IP3 receptor 2 (IP3R2) and other signaling partners. IP3R2 phosphorylation by LYN (facilitated by BANK1 scaffolding) releases calcium from the endoplasmic reticulum — the calcium flux that sustains BCR activation and drives B-cell differentiation toward antibody production.

The alanine at position 383 is highly conserved across all mammals examined²² highly conserved across all mammals examined
Conservation extends to Monodelphis domestica (opossum), indicating strong evolutionary constraint on this residue across ~180 million years of mammalian evolution, which argues for functional importance. The G allele encodes the ancestral alanine (Ala383) — the common, risk-associated form. The A allele encodes threonine (Thr383), a polar residue with a hydroxyl group that introduces a subtle conformational change in the ankyrin fold.

Threonine at this position is thought to subtly alter how the ankyrin domain docks onto IP3R2 and possibly other interaction partners. Mutations in ankyrin motifs in related proteins have been shown to alter IP3R interactions and cytoplasmic calcium mobilization³³ alter IP3R interactions and cytoplasmic calcium mobilization
Ankyrin-B ankyrin repeat mutations disrupt Na,K-ATPase/IP3R signaling microdomains and are associated with cardiac arrhythmia in other biological contexts, providing a mechanistic precedent. The net effect is that the Thr383 (A allele) form may have subtly reduced scaffold efficiency, translating to a modest dampening of BCR-evoked calcium signaling and a protective effect against B-cell hyperactivation.

The Evidence

The variant was co-discovered with rs10516487 and rs17266594 in the original BANK1 GWAS⁴⁴ original BANK1 GWAS
Kozyrev et al. performed a genome-wide scan in European-ancestry SLE patients identifying three independent BANK1 variants by Kozyrev et al. (2008, PMID 18204447). Independent replication was confirmed in Hong Kong Chinese (949 SLE patients, 1,042 controls): OR=0.84 for the A allele (P=0.021), confirming the protective effect of Thr383 across ancestries.

In systemic sclerosis⁵⁵ systemic sclerosis
Allanore et al. studied BANK1 in diffuse cutaneous SSc across combined French and German Caucasian cohorts (n=2,432 individuals), the A allele showed OR=0.73 (95% CI 0.61–0.87) against diffuse cutaneous SSc, with an A-haplotype protective OR=0.70 (P=3.39×10⁻⁴). BANK1, IRF5, and STAT4 showed additive effects in SSc risk.

In rheumatoid arthritis⁶⁶ rheumatoid arthritis
Dominguez-Soto et al. pooled data from Spanish and Argentinean RA cohorts (pooled P=0.0009, OR=1.17), the G allele was elevated in patients across four cohorts. A subsequent trans-ethnic meta-analysis⁷⁷ trans-ethnic meta-analysis
Génin et al. pooled France, Spain, and Japan RA cohorts confirmed the G allele associates with RA individually (OR=1.11, P=0.012) and identified epistatic interaction with BLK rs13277113: in individuals with the BLK GG background, the BANK1 G allele increased RA risk to OR=1.21 (95% CI 1.04–1.41, P=0.015).

In a Chinese Han cohort, rs3733197 was the only BANK1 variant significantly associated with polymyositis/dermatomyositis⁸⁸ only BANK1 variant significantly associated with polymyositis/dermatomyositis
Wang et al. studied 363 PM and 654 DM patients plus 1,280 controls; three other BANK1 SNPs were non-significant (OR=0.81, 95% CI 0.70–0.94, P=0.0183), with stronger protection for PM/DM with interstitial lung disease (P=6.0×10⁻³). In autoimmune thyroid disease, the A allele showed OR=0.73 for Hashimoto's thyroiditis (P<0.05) in a Chinese cohort.

Practical Actions

The A383T variant is a risk modifier, not a deterministic cause of autoimmune disease. The G allele (Ala383) is the common reference form carried by approximately 70% of the global population — it represents a baseline of somewhat higher B-cell signaling capacity that, in combination with other genetic and environmental factors, tips the balance toward B-cell-driven autoimmunity. The protective A allele (Thr383) provides a modest dampening of this signaling.

Practical implications are similar to those of the BANK1 rs10516487 variant, since both affect the same B-cell hyperactivation pathway. Carriers of the GG genotype face the highest population-level BANK1 contribution to autoimmune risk. Since this variant is independently associated with RA (not just SLE/SSc), awareness extends beyond the lupus spectrum to include rheumatoid arthritis signs.

The BANK1/BLK epistatic axis is especially important: the RA risk from BANK1 A383T is substantially amplified in individuals who also carry BLK rs13277113 GG. If both variants are present, the combined recommendation is for earlier and more proactive autoimmune monitoring.

Interactions

BANK1 A383T (rs3733197) shows documented epistatic interaction with BLK rs13277113 in rheumatoid arthritis. The BLK rs13277113 G allele reduces BLK kinase expression in B cells; with reduced BLK activity scaffolded by the more active Ala383 BANK1 form, the BCR signaling complex appears to hypercompensate. In the BLK GG background, the BANK1 G allele yielded RA OR=1.21 (P=0.015) — roughly double the marginal effect size of either gene alone.

BANK1 A383T was also identified as interacting with BLK in SLE susceptibility analysis (rs3733197 × rs13277113 P(interaction)=0.037 in the original Kozyrev data), confirming this epistatic relationship across both RA and SLE. This places the BANK1/BLK axis as a shared mechanistic pathway for multiple autoimmune conditions.

The relationship to the co-shipped rs10516487 (R61H, N-terminal domain) is one of independent additive effects within the same gene. Both variants contribute to BCR signaling amplification through different structural domains — rs10516487 through scaffold complex size, rs3733197 through ankyrin-domain docking efficiency. Carrying risk alleles at both positions is expected to compound the B-cell hyperactivation phenotype, though formal compound analysis has not been published for A383T + R61H specifically.